Related references
Note: Only part of the references are listed.Comment on: Anxiety and depression in patients with advanced ovarian cancer: a prospective study
Salvatore Giovanni Vitale et al.
JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY (2017)
Comment on: Needs and priorities of women with endometrial and cervical cancer
Antonio Simone Lagana et al.
JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY (2017)
Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up
Pietro Cignini et al.
UPDATES IN SURGERY (2017)
Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives
Salvatore Giovanni Vitale et al.
UPDATES IN SURGERY (2017)
Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis
Adriano Bellia et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Amancio Carnero et al.
BIOESSAYS (2016)
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?
Alessandra Fabi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review
Enrica Bentivegna et al.
LANCET ONCOLOGY (2016)
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Siming Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer
Yusuke Shiozawa et al.
ONCOTARGET (2016)
Surgical treatment of high stage endometrial cancer: current perspectives
Salvatore Giovanni Vitale et al.
UPDATES IN SURGERY (2016)
Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role?
Antonio Simone Lagana et al.
GYNECOLOGIC ONCOLOGY REPORTS (2016)
Management of uterine fibroids in pregnancy: recent trends
Salvatore G. Vitale et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2015)
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro
Francesca Ferrari et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells
Upal Basu-Roy et al.
NATURE COMMUNICATIONS (2015)
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2
Roberta Nicoletti et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Recent trends in surgical and reconstructive management of vulvar cancer: review of literature
Salvatore Giovanni Vitale et al.
UPDATES IN SURGERY (2015)
HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo
Carlton L. Schwab et al.
GYNECOLOGIC ONCOLOGY (2014)
Efficacy of IVF following conservative management of endometrial cancer
Diego Rossetti et al.
GYNECOLOGICAL ENDOCRINOLOGY (2014)
Apoptotic Death of Cancer Stem Cells for Cancer Therapy
Ying-Chun He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Perspectives on cancer stem cells in osteosarcoma
Upal Basu-Roy et al.
CANCER LETTERS (2013)
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
Baris Boyraz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer
Klaus Pietzner et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer
Goran Benko et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review
Salvatore Giovanni Vitale et al.
UPDATES IN SURGERY (2013)
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
Marion G. Ott et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas
Federica Guzzo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
S. Akunuru et al.
CELL DEATH & DISEASE (2012)
Pathology of mixed Mullerian tumours
Emanuela D'Angelo et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2011)
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
Sarah Shigdar et al.
CANCER SCIENCE (2011)
Immunity and immune suppression in human ovarian cancer
Claudia C. Preston et al.
IMMUNOTHERAPY (2011)
Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity
H. Akita et al.
ONCOGENE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
CD133+ Cancer Stem Cell-like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Mullerian Tumor)
Batsuren Choijamts et al.
STEM CELLS (2011)
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
Khadra Galaal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M. Schmidt et al.
ANNALS OF ONCOLOGY (2010)
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
K. El-Sahwi et al.
BRITISH JOURNAL OF CANCER (2010)
Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
Markus Muenz et al.
CANCER CELL INTERNATIONAL (2010)
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy
Diane Seimetz et al.
CANCER TREATMENT REVIEWS (2010)
Ovarian and Uterine Carcinosarcomas A Comparative Analysis of Prognostic Variables and Survival Outcomes
Gunjal Garg et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
EpCAM As a Target in Cancer Therapy
Olivier Gires et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The role of HER2 in cancer therapy and targeted drug delivery
Wanyi Tai et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen et al.
NATURE CELL BIOLOGY (2010)
Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
Ines Herrmann et al.
PLOS ONE (2010)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
Sergio Rutella et al.
CLINICAL CANCER RESEARCH (2009)
Cancer stem cells: never Wnt away from the niche
Ilaria Malanchi et al.
CURRENT OPINION IN ONCOLOGY (2009)
FIGO staging for uterine sarcomas
Jaime Prat
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
Anthony L. A. Fields et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
When Wishful Thinking Leads to a Misty-Eyed Appraisal: The Story of the Adjuvant Colon Cancer Trials With Edrecolomab
Hans-Joachim Schmoll et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer stem cells: mirage or reality?
Piyush B. Gupta et al.
NATURE MEDICINE (2009)
Carcinosarcoma of the Ovary A Review
Leigh A. Cantrell et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2009)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Unraveling the Biologic and Clinical Complexities of HER2
John W. Park et al.
CLINICAL BREAST CANCER (2008)
Molecular genetic aberrations of ovarian and uterine carcinosarcomas - a CGH and FISH study
Alexander Schipf et al.
VIRCHOWS ARCHIV (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells
Masanori Ono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets
David Cimbaluk et al.
GYNECOLOGIC ONCOLOGY (2007)
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer
Zsolt Gabos et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Radiation-associated endometrial cancers are prognostically unfavorable tumors: A clinicopathologic comparison with 527 sporadic endometrial cancers
Bhavana Pothuri et al.
GYNECOLOGIC ONCOLOGY (2006)
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
Gilbert Spizzo et al.
GYNECOLOGIC ONCOLOGY (2006)
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
K Brischwein et al.
MOLECULAR IMMUNOLOGY (2006)
EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma
CA Livasy et al.
GYNECOLOGIC ONCOLOGY (2006)
Amplification of c-erbB2 oncogene - A maior prognostic indicator in uterine serous papillaty carcinoma
AD Santin et al.
CANCER (2005)
COX-2, c-KIT and HER-2/neu expression in uterine carcino sarcomas: prognostic factors or potential markers for targeted therapies?
MR Raspollini et al.
GYNECOLOGIC ONCOLOGY (2005)
Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989-1999
BE Brooks et al.
GYNECOLOGIC ONCOLOGY (2004)
Malignant mixed Mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome
M Callister et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer
G Spizzo et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
ERBB-2 gene overexpression and amplification in uterine sarcomas
F Amant et al.
GYNECOLOGIC ONCOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EpCAM - A new therapeutic target for an old cancer antigen
A Armstrong et al.
CANCER BIOLOGY & THERAPY (2003)
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas
C Pauli et al.
CANCER LETTERS (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Malignant mixed mullerian tumour of the ovary: Prognostic factor and response of adjuvant platinum-based chemotherapy
P Inthasorn et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2003)
Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma
M Sawada et al.
CANCER SCIENCE (2003)
Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas
WG McCluggage
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Association of tamoxifen and uterine sarcoma
DL Wickerham et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
WG McCluggage
JOURNAL OF CLINICAL PATHOLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
